Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 52
Filter
1.
Opt Lett ; 42(20): 4167-4170, 2017 Oct 15.
Article in English | MEDLINE | ID: mdl-29028039

ABSTRACT

We report on the demonstration of a spot size converter (SSC) for monolithic photonic integration at a wavelength of 850 nm on a GaAs substrate. We designed and fabricated a dual-waveguide AlGaAs chip. The design consists of a lower waveguide layer for efficient end-fire coupling to a single-mode fiber, an upper waveguide layer for high refractive index contrast waveguides, and a vertical SSC to connect the two waveguide layers. We measured a SSC conversion efficiency of 91% (or -0.4 dB) between the upper and lower waveguide layers for the TE mode at a wavelength of 850 nm.

2.
Vox Sang ; 112(8): 713-722, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28960367

ABSTRACT

BACKGROUND AND OBJECTIVES: Interventions to prevent and detect bacterial contamination of platelet concentrates (PCs) have reduced, but not eliminated the sepsis risk. Standardized bacterial strains are needed to validate detection and pathogen reduction technologies in PCs. Following the establishment of the First International Reference Repository of Platelet Transfusion-Relevant Bacterial Reference Strains (the 'repository'), the World Health Organization (WHO) Expert Committee on Biological Standardisation (ECBS) endorsed further repository expansion. MATERIALS AND METHODS: Sixteen bacterial strains, including the four repository strains, were distributed from the Paul-Ehrlich-Institut (PEI) to 14 laboratories in 10 countries for enumeration, identification and growth measurement on days 2, 4 and 7 after low spiking levels [10-25 colony-forming units (CFU)/PC bag]. Spore-forming (Bacillus cereusPEI-B-P-07-S, Bacillus thuringiensisPEI-B-P-57-S), Gram-negative (Enterobacter cloacaePEI-B-P-43, Morganella morganiiPEI-B-P-74, PEI-B-P-91, Proteus mirabilisPEI-B-P-55, Pseudomonas fluorescensPEI-B-P-77, Salmonella choleraesuisPEI-B-P-78, Serratia marcescensPEI-B-P-56) and Gram-positive (Staphylococcus aureusPEI-B-P-63, Streptococcus dysgalactiaePEI-B-P-71, Streptococcus bovisPEI-B-P-61) strains were evaluated. RESULTS: Bacterial viability was conserved after transport to the participating laboratories with one exception (M. morganiiPEI-B-P-74). All other strains showed moderate-to-excellent growth. Bacillus cereus, B. thuringiensis, E. coli, K. pneumoniae, P. fluorescens, S. marcescens, S. aureus and S. dysgalactiae grew to >106 CFU/ml by day 2. Enterobacter cloacae, P. mirabilis, S. epidermidis, S. bovis and S. pyogenes achieved >106 CFU/ml at day 4. Growth of S. choleraesuis was lower and highly variable. CONCLUSION: The WHO ECBS approved all bacterial strains (except M. morganiiPEI-B-P-74 and S. choleraesuisPEI-B-P-78) for repository enlargement. The strains were stable, suitable for spiking with low CFU numbers, and proliferation was independent of the PC donor.


Subject(s)
Blood Platelets/microbiology , Blood Safety/standards , Platelet Transfusion , Biological Specimen Banks , Escherichia coli/growth & development , Humans , Klebsiella pneumoniae/growth & development , Reference Standards , Staphylococcus aureus/growth & development , Staphylococcus epidermidis/growth & development , World Health Organization
3.
Vox Sang ; 111(3): 226-234, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27185478

ABSTRACT

BACKGROUND AND OBJECTIVES: Blood Centre logistics, staffing and donor scheduling may be optimized if pathogen inactivation (PI) of platelets can be delayed until Day 1, but bacteria may rapidly grow during this time. This study evaluates bacterial PI performed 24 and 30 h after collection. MATERIALS AND METHODS: PAS-3 platelet units were collected on the Amicus and subsequently inoculated (3-53 CFU/unit) with 1of 5 transfusion relevant bacterial species (n = 3/organism). Units were then stored for either 24 ± 0·3 or 30 ± 0·3 h at 20-24°C with agitation, subsequently treated with amotosalen and UVA, and stored for 7 days. Samples were taken before and after inactivation, on Days 2, 5 and 7 for BacT/ALERT testing, and on Days 5 and 7 for plate counts. RESULTS: All samples from units taken prior to inactivation either demonstrated positive plate culture counts, or, in untreated positive controls, were culture-positive during storage. All contaminated units treated with amotosalen and UVA 24 after inoculation were culture-negative on all days tested. With inactivation performed 30 h following inoculation, one of 15 units (1-of-3 replicates) was culture-positive with Klebsiella pneumonia (1 × 109 CFU/ml) by Day 5. CONCLUSION: Photochemical treatment did not inactivate 1 of 15 units to sterility in apheresis platelets stored in PAS with a 30-h delay between contamination and treatment, but did inactivate 15 of 15 units with a 24-h delay.


Subject(s)
Bacteria/drug effects , Blood Platelets/cytology , Furocoumarins/pharmacology , Photosensitizing Agents/pharmacology , Bacteria/growth & development , Bacteria/radiation effects , Blood Platelets/microbiology , Humans , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/radiation effects , Platelet Count , Platelet Transfusion , Plateletpheresis , Ultraviolet Rays
4.
Vox Sang ; 108(3): 226-32, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25471280

ABSTRACT

BACKGROUND AND OBJECTIVES: Previous studies with p38MAPK inhibitors at room temperature demonstrated that they improve a large number of platelet storage parameters, but cannot substantially inhibit p38MAPK activation nor protect against widespread decrements in platelet quality parameters during 4 °C storage. In this study, platelet quality parameters and inhibition of p38MAPK by VX-702 were studied after incubation of platelets at 16 °C without agitation, suboptimal storage conditions which produce moderate platelet decrements. MATERIALS AND METHODS: Trima apheresis units were collected and aliquoted into three 60-ml CLX storage bags: (i) a control aliquot which was held at 20-24 °C with constant agitation; (ii) a test aliquot which was held at 20-24 °C with agitation until Day 2, when it was reincubated at 16 ± 1 °C for 24 ± 0·5 h without agitation and then returned 20-24 °C with agitation; (iii) a test aliquot containing 1 µm VX-702 stored in an identical fashion as aliquot 2. Aliquots were tested for an array of platelet storage parameters and p38MAPK activation on Days 1, 4 and 7. RESULTS: Many platelet storage parameters and p38MAPK activation were adversely affected by 24-h incubation at 16 °C without agitation. With the exception of ESC, addition of VX-702 prevented p38MAPK activation and the decrements in most observed parameters. CONCLUSION: Unlike 4 °C storage, VX-702 prevents activation of p38MAPK and decrements in many platelet storage parameters after exposure to 16 °C without agitation for 24 h.


Subject(s)
Blood Platelets/drug effects , Blood Preservation/methods , Enzyme Inhibitors/pharmacology , Phenylurea Compounds/pharmacology , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , Cold Temperature , Humans
5.
Vox Sang ; 107(4): 360-7, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24976248

ABSTRACT

BACKGROUND AND OBJECTIVES: Bacterial proliferation is inhibited in platelets (PLTs) stored at refrigerated temperatures, but also dramatically decreases PLT in vivo survival. Recent studies have demonstrated that cold temperature (CT) stored PLTs secrete sialidases upon re-warming, removing sialic acid from the PLT surface, which may be responsible for clustering of GPIbα and PLT clearance from circulation. In this study, the influence of a sialidase inhibitor or a p38 MAP kinase inhibitor was evaluated in units stored at 4 °C. MATERIALS AND METHODS: After collection of a single Trima apheresis unit (n = 12), PLTs were aliquoted into four 60-ml CLX storage bags. One bag was stored at 20-24 °C (RT) with continuous agitation; a second bag was stored at 4 °C without agitation; a third bag was held at 4 °C without agitation with sialidase inhibitor, a fourth bag was incubated at 4 °C with a p38 MAPK inhibitor without agitation. RESULTS: Beginning from Day 1, all in vitro PLT parameters were adversely affected by CT compared to those of RT. Similar in vitro storage properties were observed in CT PLT in the presence or absence of sialidase or p38 MAPK inhibitors. P38 MAPK phosphorylation inhibition was not observed at CT. Decrease of sialidase activity was observed for 2 days in PLTs stored in additive solution but not in plasma. CONCLUSION: Addition of either sialidase or p38 MAPK inhibitors do not improve any in vitro parameters of PLTs stored at 4 °C in 100% plasma.


Subject(s)
Blood Platelets/drug effects , Blood Preservation , Enzyme Inhibitors/pharmacology , Neuraminidase/antagonists & inhibitors , Protein Kinase Inhibitors/pharmacology , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , Blood Component Removal , Blood Platelets/metabolism , Cold Temperature , Humans , Neuraminidase/metabolism , Phosphorylation , Platelet Aggregation/physiology , Time Factors , p38 Mitogen-Activated Protein Kinases/metabolism
6.
Vox Sang ; 106(4): 337-43, 2014 May.
Article in English | MEDLINE | ID: mdl-24330192

ABSTRACT

BACKGROUND AND OBJECTIVES: PLT additive solutions (PAS) are useful for reducing the frequency and/or severity of plasma-associated transfusion reactions. A new PAS solution, PAS-5, containing 5% plasma, maintains in vitro PLT properties during 7-day storage. Periods with interruption of agitation (IA) ≤24 h routinely occur during PLT shipment and do not usually compromise platelet quality. The aim of the study was to evaluate the properties of PLTs stored for 7 days in 95% PAS-5/5% plasma subjected to a 24-h IA. MATERIALS AND METHODS: Double apheresis Amicus units (n = 12) were collected using a manual PAS-5 addition to hyperconcentrated PLTs. PLT units were equally divided in two containers. Control and test PLTs were stored with continuous agitation at 20-24°C except for 24-h IA period for test units between days 2-3. RESULTS: During storage, levels of glucose, lactate, mitochondrial membrane potential and aggregation significantly differed in test units compared to those of control. The pH levels of test PLTs were less than those of control units with 7/12 test units having pHs <6·2 on Day 7 compared to 1/12 control units. Morphology score, GP1bα expression, ESC values, superoxide production were also less, and activation was greater in test PLTs than those of control. All other parameters were similar between test and control units. CONCLUSION: PLTs stored in PAS-5 solution containing 5% plasma with a 24-h IA results in marked decrements in many in vitro PLT quality parameters during 7-day storage.


Subject(s)
Bicarbonates/chemistry , Blood Platelets/physiology , Blood Preservation/methods , Glucose/metabolism , Humans , Hydrogen-Ion Concentration , Lactic Acid/metabolism , Membrane Potential, Mitochondrial , Plasma , Plateletpheresis , Solutions
7.
Vox Sang ; 106(1): 23-30, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23815166

ABSTRACT

BACKGROUND: Platelet septic reactions result from low concentrations of bacteria that escape detection by quality-control BacT/ALERT™ culture testing. We estimate the contamination rate with these bacteria at the time of testing using a mathematical model. METHODS: Culture results and reported septic reactions are described for platelets collected between January 2007 and December 2011. Initial positive results with negative confirmatory cultures were reclassified assuming some of the 'unconfirmed positive results' represent collections contaminated with low-concentration, dormant bacteria. A mathematical model based on the probability of the detection of bacteria describes the upper limit of the residual rate of contamination. RESULTS: The rate of confirmed or unconfirmed positive apheresis platelet donations was 188 per million (1:5317) and 110 per million (1:9124), respectively. The rate of post-transfusion sepsis and reported fatalities per distributed component was 1:106 931 and 1:1 015 843, respectively. A linear decrease in unconfirmed positive Bacillus spp. cultures most likely reflected diminishing environmental contamination over time. The remaining unconfirmed positive results identified similar bacteria species as those associated with septic reactions. Assuming that these represent contamination of the collection with low-concentration, dormant bacteria, the model identified a residual contamination of 3524-204 per million (1:284-1:4902) for collections contaminated with 1-20 bacteria, respectively. DISCUSSION: Greater than 99·5% of collections contain no viable, aerobic bacteria in solution at the time of early culture testing. For every confirmed positive contaminated collection detected, there are at most 19 collections with low concentrations of dormant bacteria that are not readily detected by early BacT/ALERT™ culture.


Subject(s)
Bacteria, Aerobic/isolation & purification , Blood Platelets/microbiology , Equipment Contamination/statistics & numerical data , Plateletpheresis/adverse effects , Sepsis/etiology , Bacterial Load , Humans , Models, Theoretical , Plateletpheresis/instrumentation , Quality Control
8.
Opt Lett ; 37(23): 4814-6, 2012 Dec 01.
Article in English | MEDLINE | ID: mdl-23202055

ABSTRACT

We experimentally demonstrate a transverse electric (TE)-pass polarizer using the recently proposed hybrid plasmonic waveguide. The device consists of a silicon film separated from a chromium layer by a silica spacer. The device was characterized using a tunable laser in the 1.52-1.58 µm wavelength range. For a 30 µm long polarizer, the extinction ratio in this wavelength range varies from 23 to 28 dB and the insertion loss for the TE mode is 2-3 dB. The device is compact; its fabrication is completely compatible with silicon-on-insulator technology, and its performance compares favorably against previously reported silicon-based integrated optic TE-pass polarizers.

9.
Vox Sang ; 100(1): 112-21, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21175661

ABSTRACT

Numerous studies have evaluated a wide variety of photosensitizers and alkylating agents as candidates for a pathogen reduction process to be used in RBC suspensions. The methodologies that produce robust inactivation of pathogens with maintenance of RBC properties during storage involve those that specifically target nucleic acids. This has been demonstrated through in vitro studies by flexible photosensitizers, which specifically target nucleic acid but do not engage in photochemistry when free in solution and nucleic acid alkylating agents in conjunction with extracellular quencher(s) to protect against RBC membrane alkylation. The flexible photosensitizer method must be scaled up to entire units, and toxicology studies would need to be performed for further development. Clinical trials will ultimately be necessary to further develop either flexible photosensitizers or nucleic acid alkylating methods with quenchers for use in Transfusion Medicine.


Subject(s)
Blood Safety/methods , Disease Transmission, Infectious/prevention & control , Erythrocytes/drug effects , Alkylating Agents/pharmacology , Erythrocyte Transfusion/adverse effects , Erythrocytes/microbiology , Erythrocytes/parasitology , Humans , In Vitro Techniques , Nucleic Acids/drug effects , Nucleic Acids/radiation effects , Photosensitizing Agents/pharmacology
10.
Lupus ; 18(4): 342-7, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19276302

ABSTRACT

The objective of this study was to determine the impact of lupus nephritis disease activity on maternal and foetal outcomes in pregnant patients with systemic lupus erythematosus (SLE). Medical records of all pregnant patients with SLE treated at our institution between 1976 and 2007 were reviewed. All patients met American College of Rheumatology classification criteria for SLE. Demographic data, history of lupus nephritis, nephritis disease activity and maternal and foetal outcomes of pregnancy were abstracted. Active lupus nephritis was defined as the presence of proteinuria >0.5 g/day and/or active urinary sediment with or without an elevation in serum creatinine (Cr). Quiescent lupus nephritis was confirmed in the presence of proteinuria <0.5 mg/day and inactive urinary sediment. We identified 58 patients with 90 pregnancies. Compared with pregnancies in SLE patients without renal involvement (n = 47), pregnancies in patients with active lupus nephritis (n = 23) were associated with a higher incidence of maternal complications (57% vs 11%, P < 0.001), whereas those with quiescent lupus nephritis (n = 20) were not (35% vs 11%, P = 0.10). Women with active lupus nephritis were more likely to deliver preterm than women without lupus nephritis, median of 34 weeks vs 40 gestational weeks, respectively (P = 0.002) and were more likely to suffer foetal loss (35% vs 9%, P = 0.031). Active, but not quiescent, lupus nephritis during pregnancy is associated with a higher incidence of maternal and foetal complications compared with pregnancies in SLE patients without renal involvement.


Subject(s)
Lupus Erythematosus, Systemic/complications , Lupus Nephritis/complications , Pregnancy Complications/etiology , Pregnancy Outcome , Adult , Creatinine/blood , Female , Fetal Death/epidemiology , Fetal Death/etiology , Humans , Lupus Erythematosus, Systemic/physiopathology , Lupus Nephritis/physiopathology , Pregnancy , Premature Birth/epidemiology , Premature Birth/etiology , Proteinuria/etiology , Retrospective Studies , Young Adult
11.
Emerg Med J ; 25(7): 459, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18573972

ABSTRACT

Cerebral infarctions can have many presentations ranging from hemiparesis to subtle behavioural changes. A case is presented in which the only sign of a left basal ganglion infarct was isolated abulia. This case highlights the importance of a thorough evaluation in cases of acute unexplained changes in behaviour.


Subject(s)
Basal Ganglia , Cerebral Infarction/complications , Mental Disorders/etiology , Stroke/complications , Cerebral Infarction/diagnostic imaging , Humans , Male , Middle Aged , Stroke/diagnostic imaging , Tomography, X-Ray Computed
12.
Vox Sang ; 92(2): 157-9, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17298580

ABSTRACT

Recently, we have shown that thiopyrylium has robust inactivation capabilities against a broad spectrum of pathogens in the human red blood cell (RBC) suspensions while retaining key RBC in vitro properties. The 24-h recovery and survival of canine red cells were measured upon autologus reinfusion of control and phototreated units. The 24-h recovery of control and phototreated RBCs was 75.7 +/- 6.4% and 87.5 +/- 8.5%, respectively. The time for 50% survival of labelled control RBCs was similar to that of phototreated group (206 +/- 58 h vs. 255 +/- 63 h, respectively). Results suggest that thiopyrylium phototreatment does not negatively affect canine RBC in vivo recovery.


Subject(s)
Aniline Compounds/pharmacology , Blood Preservation/methods , Erythrocytes/drug effects , Hemolysis/drug effects , Photosensitizing Agents/pharmacology , Pyrans/pharmacology , Animals , Bacterial Infections/prevention & control , Cell Survival , Decontamination/methods , Dogs , Erythrocyte Membrane/drug effects , Erythrocytes/microbiology , Erythrocytes/virology , Models, Animal , Virus Diseases/prevention & control
13.
Vox Sang ; 91(2): 178-80, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16907880

ABSTRACT

BACKGROUND AND OBJECTIVES: Leishmaniasis is a disease caused by protozoan parasites of the genus Leishmania, which are intracellular parasites of monocytes and macrophages. Transmission of the organism has been observed by transfusion of infected blood from asymptomatic donors to immunocompromised recipients, leading to clinically apparent disease. There is no licensed Leishmania screening test currently available. MATERIALS AND METHODS: This study investigated the potential for a novel DNA-intercalating photosensitizer, thiopyrylium (TP), to inactivate Leishmania donovani infantum in red cell (RBC) suspensions. RESULTS: A 5.7 TCID50 reduction of Leishmania was observed in samples treated with 12.5 micromole l(-1) TP and 1.1 J cm(-2) light. CONCLUSIONS: Leishmania is highly sensitive to photoinactivation under conditions that have been previously demonstrated to maintain RBC properties during 42 days of storage.


Subject(s)
Blood Preservation/methods , Erythrocytes/parasitology , Leishmania infantum/drug effects , Leishmaniasis, Visceral/prevention & control , Photosensitizing Agents/pharmacology , Sterilization/methods , Animals , Erythrocyte Transfusion , Hemolysis/drug effects , Humans
14.
Transfus Med ; 16(4): 261-5, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16879154

ABSTRACT

Gamma irradiation (GI) can prevent transfusion-associated graft-vs.-host disease, result in a small decrement in 24-h in vivo red blood cell (RBC) recovery and in a minor loss of maintenance of several in vitro parameters during routine storage. Results from studies by Davey et al. (Transfusion 1995, 35, 55S) demonstrated that the decrement in 24-h recovery was not observed if units were first leucoreduced (LR), suggesting that RBC damage on leucocytes from GI was secondary to the effects of irradiation . In this study, we further investigated how leucoreduction affected eight in vitro storage parameters of gamma-irradiated units by using a matched sample study design. Leucoreduction significantly reduced (P < 0.05) the deleterious effect of GI on adenosine triphosphate glucose levels, haemolysis and mean corpuscular volume (MCV) for AS-3 units and significantly decreased (P < 0.05) the deleterious effect of GI on glucose levels, haemolysis and MCV for AS-1 units. Leucoreduction did not influence (P >> 0.5) the enhanced potassium release associated with GI. Some, but not all, the observed RBC damage caused by GI appears to be secondary to the effect of irradiation on leucocytes. Based on the in vivo survival studies of Davey et al. and the results of this study, there is justification to consider performing additional survival studies to support extended storage of LR gamma-irradiated RBC.


Subject(s)
Blood Preservation/methods , Erythrocyte Transfusion/standards , Gamma Rays , Adenosine Triphosphate/analysis , Blood Preservation/standards , Erythrocyte Indices , Glucose/analysis , Hemolysis , Humans , Leukocyte Reduction Procedures , Potassium/metabolism
15.
Vox Sang ; 86(3): 157-63, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15078249

ABSTRACT

Records of the transmission of bacterial infections by transfusion date back to the beginning of organized blood banking. Despite tremendous strides in preventing viral infection through careful donor screening and viral testing, there has been little improvement in reducing the risk of bacterial sepsis since the introduction of closed collection systems. Based on the French Haemovigilance study, the British Serious Hazards of Transmission (SHOT) study and fatality reports to the United States Food and Drug Administration, the risk of clinically apparent sepsis exceeds the risk of HIV, HBV, and HCV transmission. Sources of contamination include the skin, blood, disposables, and the environment. Potential interventions to reduce transfusion-associated bacterial sepsis include improvements to donor arm preparation, diversion of the first aliquot of whole blood, introduction of bacterial testing and/or implementation of pathogen reduction methods.


Subject(s)
Bacteremia/transmission , Disease Transmission, Infectious , Transfusion Reaction , Bacteremia/blood , Bacteremia/economics , Bacteremia/epidemiology , Bacteremia/prevention & control , Bacteriological Techniques , Blood Cells/microbiology , Blood Component Transfusion/adverse effects , Blood Component Transfusion/economics , Blood Transfusion/economics , Blood Transfusion/instrumentation , Blood-Borne Pathogens , Cost-Benefit Analysis , Disease Transmission, Infectious/prevention & control , Disinfection , Equipment Contamination , Humans , Risk , Skin/microbiology
16.
Biotech Histochem ; 78(3-4): 171-7, 2003.
Article in English | MEDLINE | ID: mdl-14714880

ABSTRACT

Despite recent advances in blood safety by careful donor selection and implementation of infectious disease testing, transmission of viruses, bacteria and parasites by transfusion can still rarely occur. One approach to reduce the residual risk from currently tested pathogens and to protect against the emergence of new ones is to investigate methods for pathogen inactivation. The use of photosensitizing dyes for pathogen inactivation has been studied in both red cell and platelet blood components. Optimal properties of sensitizing dyes for use in red cell suspensions include selection of dyes that traverse cell and viral membranes, bind to nucleic acids, absorb light in the red region of the spectrum, inactivate a wide range of pathogens, produce little red cell photodamage from dye not bound to nucleic acid and do not hemolyze red cells in the dark. Early research at the American Red Cross focused on the use of a class of dyes with rigid structures, such as the phenothiazine dyes, beginning with the prototypical sensitizer methylene blue. Results revealed that methylene blue phototreatment could inactivate extracellular virus, but resulted in undesirable defects in the red cell membrane that resulted in enhanced hemolysis that became evident during extended refrigerated blood storage. In addition, methylene blue phototreatment could neither inactivate intracellular viruses nor appreciably inactivate bacteria under conditions of extracellualar viral killing. Attempts to improve intracellular viral inactivation led to the investigations of more hydrophobic phenothiazines, such as methylene violet or dimethylmethylene blue. Although these dyes could inactivate intracellular virus, problems with increased red cell membrane damage and hemolysis persisted or increased. Further studies using red cell additive storage solutions containing high levels of the impermeable ion, citrate, to protect against colloidal osmotic hemolysis as well as competitive inhibitors to limit sensitizer binding to red cell membranes revealed that photoinduced hemolysis stemmed from dye bound to the red cell membrane as well as dye free in solution. Use of red cell additive solutions to prevent colloidal-osmotic hemolysis and use of novel flexible dyes that only act as sensitizers when bound to their targets are two techniques that currently are under investigation for reducing red cell damage. Ultimately, the decision to implement a photodynamic method for pathogen reduction will be determined by weighing the risks of unintended adverse consequences of the procedure itself, such as the potential for genotoxicity and allergic reactions, against the cost and benefits of its implementation.


Subject(s)
Coloring Agents/pharmacology , Erythrocytes/drug effects , Erythrocytes/virology , Photosensitizing Agents/pharmacology , Coloring Agents/chemistry , Erythrocytes/radiation effects , Hemolysis/drug effects , Hemolysis/radiation effects , Humans , Phenothiazines/chemistry , Phenothiazines/pharmacology , Photosensitizing Agents/chemistry
17.
Transfusion ; 41(11): 1351-5, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11724977

ABSTRACT

BACKGROUND: Many methods have been tested for the detection of bacterial contamination in platelets. However, only those using molecular biology or cell culturing consistently detect contamination at levels below 10(5) bacteria per mL. This report describes the initial investigation into an alternative method that offers the possibilities of high sensitivity and rapid response while using available laboratory equipment and supplies. This method relies on a fluorescent nucleic acid stain, which preferentially stains bacteria but not platelets, and automated epifluorescence microscopy for rapid analysis. Measurements in WBC-reduced platelet concentrates (PCs) contaminated with bacteria are reported at concentrations between 10(3) and 10(6) bacteria per mL. STUDY DESIGN AND METHODS: Staphylococcus epidermidis or Escherichia coli was inoculated into aliquots of WBC-reduced PCs on Days 2 through 5 of storage. Bacterially inoculated and control PCs were stained, platelets and residual WBCs were lysed, and 200 microL of sample was filtered onto black polycarbonate filters. All preparations were done in triplicate. An automated epifluorescence microscope examined approximately 2 percent of the area of each filter and used image analysis to select the fluorescent particles that should be counted as bacteria. RESULTS: Samples containing 3 to 5 x 10(3) bacteria per mL produced about three times as many fluorescent particles classified as bacteria as the controls. Lower concentrations of S. epidermidis were detected because of higher fluorescence intensity. Simultaneous preparation of six samples requires about 35 minutes. Analysis of each prepared sample takes 10 minutes, for a total preparation and analysis time of about 95 minutes for 6 samples. CONCLUSION: Low concentrations (<5 x 10(3) bacteria/mL) of deliberately inoculated S. epidermidis or E. coli can be measured quickly in WBC-depleted PCs by using a fluorescent nucleic acid stain, differential lysis, and automated microscopy. Continued refinement of the method, studies employing other bacterial strains, and further validations of assay performance are warranted.


Subject(s)
Blood Platelets/microbiology , Escherichia coli/isolation & purification , Leukapheresis , Microscopy, Fluorescence , Staphylococcus epidermidis/isolation & purification , Automation , Colony Count, Microbial , Humans , Reference Values , Time Factors
18.
Transfusion ; 41(9): 1154-8, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11552074

ABSTRACT

BACKGROUND: Dimethylmethylene blue (DMMB) has been used to photoinactivate a number of model viruses, including VSV, in RBC suspensions under conditions that preserve in vitro RBC properties during storage. The relative sensitivity of duck HBV (DHBV) and VSV to photoinactivation by DMMB was investigated by performing an indirect immunofluorescence assay (IFA) using primary duck hepatocyte (PDH) cultures or a standard plaque assay for the respective viruses. STUDY DESIGN AND METHODS: DMMB was added to 45-percent Hct, WBC-reduced, oxygenated AS-3 RBCs at 10-, 1-, and 0.1-microM concentrations. Samples (1-mm thick) were illuminated with 5.4-mW per cm(2) of red light for 2 or 9 seconds. Unilluminated samples without DMMB or with 10 microM DMMB served as control. RESULTS: DHBV and VSV were rapidly photoinactivated by DMMB in a concentration and light-dose-dependent fashion. Neither virus was substantially inactivated by incubation with DMMB in the dark. For a given light exposure, DHBV required a concentration of DMMB one-one hundredth that of VSV to achieve approximately the same level of inactivation. CONCLUSION: DHBV appears to be considerably more sensitive than VSV to DMMB photoinactivation. Photoinactivation in 45-percent Hct RBCs can be achieved in seconds by using micromolar quantities of dye.


Subject(s)
Erythrocytes/virology , Hepatitis B Virus, Duck/drug effects , Hepatitis B Virus, Duck/radiation effects , Light , Methylene Blue/pharmacology , Virus Activation/drug effects , Dose-Response Relationship, Drug , Dose-Response Relationship, Radiation , Fluorescent Antibody Technique, Indirect , Humans , Methylene Blue/analogs & derivatives
19.
Biol Pharm Bull ; 24(4): 418-21, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11305606

ABSTRACT

The participation of reactive oxygen species (ROS) in virus inactivation by 1,9-dimethylmethylene blue (DMMB) phototreatment in stroma-free hemoglobin (SFH) was investigated with the use of scavengers, quenchers and enhancer. Virus (R17 bacteriophage) photoinactivation by either activated monomer or dimer DMMB was suppressed by sodium azide (singlet oxygen quencher) and promoted by the substitution of H2O for deuterium oxide (D2O), which is known to prolong the lifespan of singlet oxygen. There was no or little effect of mannitol (hydroxyl radical scavenger) and superoxide dismutase (superoxide scavenger) on the photoinactivation. Similar experiments were conducted to investigate the mechanism of methemoglobin (Met-Hb) formation by the activated monomer of DMMB. There was little effect of the singlet oxygen quencher, histidine, or the enhancer, D2O, on Met-Hb formation. However, rutin, which inhibits not only singlet oxygen but also other ROS, and mannitol supressed the formation of Met-Hb by activated monomer. The addition of superoxide dismutase (SOD) did not inhibit the formation. In contrast to the activity of the DMMB monomer, that of the dimer was inhibited by histidine and enhanced by D2O. The addition of neither mannitol nor SOD affected Met-Hb formation by activated dimer. These results collectively suggest that virus photoinactivation by the activated monomer and dimer of DMMB as well as Met-Hb formation by the activated dimer proceed via a singlet oxygen mediated pathway. In contrast, singlet oxygen may play a less important role in Met-Hb formation by the activated monomer.


Subject(s)
Bacteriophages/drug effects , Bacteriophages/radiation effects , Hemoglobins/metabolism , Methylene Blue/pharmacology , Reactive Oxygen Species/metabolism , Catalase/pharmacology , Free Radical Scavengers/pharmacology , Humans , Light , Methylene Blue/analogs & derivatives , Oxidation-Reduction , Superoxide Dismutase/pharmacology
20.
Transfusion ; 40(8): 968-75, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10960525

ABSTRACT

BACKGROUND: The transfusion of blood components containing WBCs can cause unwanted complications, which include virus transmission, transfusion-associated GVHD, alloimmunization, febrile reactions, and immunomodulation. Phototreatment with 4 microM of dimethylmethylene blue (DMMB) and 13 J per cm(2) of white light irradiation has previously been shown to be an effective way to inactivate different models of enveloped and nonenveloped viruses in RBC suspensions, with minimum damage to RBCs. The present study compares WBC photoinactivation in buffy coat after DMMB or MB phototreatment under virucidal conditions. STUDY DESIGN AND METHODS: Buffy coat diluted to 30-percent Hct was treated with the dye and white light. Isolated WBCs were assayed for cell proliferation and viability by an assay using a tetrazolium compound, limiting dilution analysis, DNA fragmentation, and flow cytometry assays. RESULTS: DMMB and 2.5 J per cm(2) of light phototreatment can inactivate T cells to the limit of detection by limiting dilution analysis (>4.76 log reduction). No WBC proliferation activity was observed after DMMB and 3.8 J per cm(2) of light. DNA degradation after DMMB phototreatment was light dependent. In addition, DMMB phototreatment induced apoptosis in WBCs. In contrast, MB phototreatment under virucidal conditions did not cause significant changes in the viability of WBCs. Neither DNA degradation nor signs of apoptosis were observed after MB phototreatment. CONCLUSION: DMMB phototreatment inactivates T-lymphocytes, the cells that cause GVHD.


Subject(s)
Coloring Agents/pharmacology , Erythrocytes , Leukocytes , Methylene Blue/analogs & derivatives , Phenothiazines/pharmacology , DNA Fragmentation , Flow Cytometry , Humans , Leukocytes/metabolism , Leukocytes, Mononuclear , Light , Methylene Blue/pharmacology , Photosensitizing Agents/pharmacology , Propidium/pharmacokinetics , Virus Activation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...